Meet South Florida’s Local Leaders
December 21, 2018
Tips From the Top of South Florida's Businesses
On this episode of The Balancing Act: South Florida Edition, host Olga Villaverde sits down with the leaders of three successful South Florida businesses.
Life coach Roy Assad is back at The Balancing Act studio ready to share another helpful tip: Discover your unique quality and delegate the rest. Here’s why.
Did you know traditional Chinese medicine provides a holistic approach to relieve pain, treat chronic illness, and promote health and wellness? At the Atlantic Institute of Oriental Medicine (ATOM), students are trained in the philosophy of traditional Chinese medicine with the goal of becoming highly-skilled practitioners.
Then, hear about Beth El Mausoleum. It’s more than just a final resting place–it offers a Jewish community, and connections with clergy for pastoral care, spiritual guidance, and Jewish tradition.
Craving a delicious, homemade meal without the stress of planning and prep? We’re back in the kitchen with celebrity chef Ralph Pagano for a QuickBytes featuring Orrington Farms, a line of broth bases and flavorful seasonings guaranteed to add wholesome, farm fresh flavor to your recipes.
If you’ve been suffering from a chronic or recurrent infection, you’re not alone. Learn how MicroGenDX’s Next Generation DNA Sequencing is changing the lives of patients around the world.
Bringing the best tips from the experts in Atlanta in business, beauty, wealth management, child healthcare, car shopping, and more. Each year, Atlanta’s Women’s Entrepreneurship Initiative selects 15 local female entrepreneurs for a 15-month business training program. We meet women who have grown their companies, created jobs, and broke through the glass ceiling. With some […]
iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.
There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.